|
|
Volumn 54, Issue SUPPL. 4, 1997, Pages 22-29
|
|
Clinical efficacy and prospects for use of pegylated liposomal doxorubicin in the treatment of ovarian and breast cancers
|
|
Author keywords
[No Author keywords available]
|
|
Indexed keywords
ANTINEOPLASTIC AGENT;
CISPLATIN;
CYCLOPHOSPHAMIDE;
DOCETAXEL;
DOXORUBICIN;
GRANULOCYTE COLONY STIMULATING FACTOR;
LIPOSOME;
PACLITAXEL;
PREDNISONE;
VINCRISTINE;
ALOPECIA;
ANIMAL EXPERIMENT;
ANIMAL MODEL;
ANTINEOPLASTIC ACTIVITY;
BONE MARROW SUPPRESSION;
BREAST CANCER;
CANCER GRAFT;
CARDIOTOXICITY;
CLINICAL TRIAL;
DRUG EFFICACY;
DRUG TOLERABILITY;
HUMAN;
LYMPHOMA;
MAINTENANCE THERAPY;
MAJOR CLINICAL STUDY;
META ANALYSIS;
NAUSEA;
NONHUMAN;
OVARY CANCER;
QUALITY OF LIFE;
REVIEW;
VOMITING;
ANIMALIA;
MURINAE;
MUS MUSCULUS;
|
|
EID: 0030660141
PISSN: 00126667
EISSN: None
Source Type: Journal
DOI: 10.2165/00003495-199700544-00006 Document Type: Review |
|
Times cited : (81)
|
|
References (44)
|
